[1]
BEKADJA, M.A. 2017. OUTCOME OF FRONTLINE TREATMENT WITH “GENERIC” IMATINIB IN ADULT PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN ALGERIAN POPULATION: A MULTICENTER STUDY. Mediterranean Journal of Hematology and Infectious Diseases. 9, 1 (Oct. 2017), e2017062. DOI:https://doi.org/10.4084/mjhid.2017.062.